Univest
Univest
  • Markets

Is Jeena Sikho Lifecare the Best Stock in Its Sector? A Look at the Numbers

  • September 29, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Is Jeena Sikho Lifecare the Best Stock in Its Sector? A Look at the Numbers

Jeena Sikho Lifecare CMP Rs 489 (29 Sep 2026). Market cap Rs 6,245 Cr. ROE 47.50%. P/E 26.43x versus Industry P/E 38.42x.

Quick Answer

Jeena Sikho Lifecare is one of the names investors compare when screening the Healthcare sector, built on a 47.50% return on equity and a P/E of 26.43x against an Industry P/E of 38.42x. Whether Jeena Sikho Lifecare is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.

Is Jeena Sikho Lifecare the best stock in its sector? The stock trades on the NSE at Rs 489 as of 29 September 2026, within its 52-week range of Rs 485.10 to Rs 839.00. Jeena Sikho Lifecare Ltd operates dialysis and kidney care centres across India.

Jeena Sikho Lifecare sits in the Healthcare sector, and its 47.50% ROE and 26.43x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • About Jeena Sikho Lifecare
  • Is Jeena Sikho Lifecare the Best Stock in Its Sector?
  • How Jeena Sikho Lifecare Compares Against Its Healthcare Sector Peers
  • What Makes Jeena Sikho Lifecare Worth Watching in Healthcare
  • Jeena Sikho Lifecare Valuation: Is It Justified?
  • How to Track Jeena Sikho Lifecare Before You Invest
  • Conclusion
    • Is Jeena Sikho Lifecare the best stock in its sector?
    • What is the current share price of Jeena Sikho Lifecare?
    • What sector does Jeena Sikho Lifecare belong to?
    • How does Jeena Sikho Lifecare compare to its sector peers on P/E?
    • What is Jeena Sikho Lifecare’s return on equity?
    • Should I invest in Jeena Sikho Lifecare based on its sector position?

About Jeena Sikho Lifecare

Jeena Sikho Lifecare Ltd operates dialysis and kidney care centres across India. The stock fell 2.5 percent during this session and is trading at its 52-week low, having roughly halved from its high. At a market capitalisation of Rs 6,245 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Jeena Sikho Lifecare the Best Stock in Its Sector?

Jeena Sikho Lifecare makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 47.50% ROE with a 26.43x P/E against the sector’s 38.42x Industry P/E. Jeena Sikho Lifecare’s 26.43x P/E is well below the 38.42x Industry P/E despite an exceptional 47.50% ROE, but the stock is at its 52-week low after roughly halving from its high, so the market is clearly reassessing its growth assumptions.

Metric Jeena Sikho Lifecare
CMP (NSE) Rs 489.35
52-Week High / Low Rs 839.00 / Rs 485.10
Market Cap Rs 6,245 Cr
P/E (TTM) vs Industry P/E 26.43x vs 38.42x
P/B 13.37
ROE 47.50%
EPS (TTM) Rs 19.01
Dividend Yield 0.90%
Debt to Equity 0.27

Compare Jeena Sikho Lifecare Against Other Healthcare Sector Stocks

How Jeena Sikho Lifecare Compares Against Its Healthcare Sector Peers

The table below sets Jeena Sikho Lifecare against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company Market Cap (Rs Cr) P/E ROE Debt to Equity
Jeena Sikho Lifecare 6,245 26.43 47.50% 0.27
Gaudium IVF and Women Health 844 36.48 16.06% 0.16
Gujarat Kidney and Super Speciality 1,347 80.59 6.14% 0.12
Peer average (2 companies) – 58.53 11.10% 0.14

Against this peer set, Jeena Sikho Lifecare’s 47.50% ROE is above the 11.10% peer average, and its P/E of 26.43x runs below the peer average of 58.53x. Jeena Sikho Lifecare’s 26.43x P/E is well below the 38.42x Industry P/E despite an exceptional 47.50% ROE, but the stock is at its 52-week low after roughly halving from its high, so the market is clearly reassessing its growth assumptions.

What Makes Jeena Sikho Lifecare Worth Watching in Healthcare

  • Exceptional ROE: A 47.50% ROE is one of the highest in this entire series.
  • Well below Industry P/E: A 26.43x P/E against a 38.42x Industry P/E is a discount for that level of ROE.
  • Sharp fall toward its 52-week low: The stock fell 2.5 percent during this session and is now at its 52-week low, having roughly halved from its high, which is worth understanding before treating the low P/E as a bargain.

Jeena Sikho Lifecare Valuation: Is It Justified?

Jeena Sikho Lifecare’s 26.43x P/E is well below the 38.42x Industry P/E despite an exceptional 47.50% ROE, but the stock is at its 52-week low after roughly halving from its high, so the market is clearly reassessing its growth assumptions. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is INOX India the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Jeena Sikho Lifecare and other Healthcare sector stocks.

How to Track Jeena Sikho Lifecare Before You Invest

Before deciding whether Jeena Sikho Lifecare deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

  1. Open the Univest Screener and search for Jeena Sikho Lifecare to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
  2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
  3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
  4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Jeena Sikho Lifecare earns a place in the best stock in its sector conversation on the strength of a 47.50% ROE and a P/E of 26.43x against a 38.42x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Is Jeena Sikho Lifecare the best stock in its sector?

Ans. Jeena Sikho Lifecare has a 47.50% ROE and trades at 26.43x P/E against a 38.42x Industry P/E, and compares above the peer average ROE of 11.10% in this article’s named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Jeena Sikho Lifecare?

Ans. Jeena Sikho Lifecare was trading at Rs 489.35 on the NSE as of 29 September 2026, within its 52-week range of Rs 485.10 to Rs 839.00.

What sector does Jeena Sikho Lifecare belong to?

Ans. Jeena Sikho Lifecare is classified under the Healthcare sector on Univest.

How does Jeena Sikho Lifecare compare to its sector peers on P/E?

Ans. Jeena Sikho Lifecare’s P/E of 26.43x is below the 58.53x average of the 2 named peers compared in this article.

What is Jeena Sikho Lifecare’s return on equity?

Ans. Jeena Sikho Lifecare reported a return on equity of 47.50%, which is above the 11.10% average of its named peers in this comparison.

Should I invest in Jeena Sikho Lifecare based on its sector position?

Ans. Jeena Sikho Lifecare’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “Is Jeena Sikho Lifecare the best stock in its sector?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Jeena Sikho Lifecare has a 47.50% ROE and trades at 26.43x P/E against a 38.42x Industry P/E, and compares above the peer average ROE of 11.10% in this article’s named comparison, so the answer depends on what an investor is prioritising.”}}, {“@type”: “Question”, “name”: “What is the current share price of Jeena Sikho Lifecare?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Jeena Sikho Lifecare was trading at Rs 489.35 on the NSE as of 29 September 2026, within its 52-week range of Rs 485.10 to Rs 839.00.”}}, {“@type”: “Question”, “name”: “What sector does Jeena Sikho Lifecare belong to?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Jeena Sikho Lifecare is classified under the Healthcare sector on Univest.”}}, {“@type”: “Question”, “name”: “How does Jeena Sikho Lifecare compare to its sector peers on P/E?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Jeena Sikho Lifecare’s P/E of 26.43x is below the 58.53x average of the 2 named peers compared in this article.”}}, {“@type”: “Question”, “name”: “What is Jeena Sikho Lifecare’s return on equity?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Jeena Sikho Lifecare reported a return on equity of 47.50%, which is above the 11.10% average of its named peers in this comparison.”}}, {“@type”: “Question”, “name”: “Should I invest in Jeena Sikho Lifecare based on its sector position?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Jeena Sikho Lifecare’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.”}}]}



sector stocks Stock Market
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply